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Emphysematous pyelonephritis (EPN) is an uncom-
mon but life-threatening acute, severe, necrotizing
infection of the renal parenchyma and surrounding
areas, characterized by the presence of gas within 
the renal parenchyma, collecting system, and or peri-
nephric tissue [1]. EPN deserves special attention be-
cause of its septic complications with life-threatening
potential. EPN is caused by gas-forming organisms
and almost always occurs in patients with uncontrolled
diabetes mellitus (DM), with or without obstructive
uropathy [2]. Traditionally, management of EPN is
aggressive, and surgery is mandatory [3–6]. However,
EPN has also been successfully treated with antibi-
otics, with or without percutaneous catheter drainage
(PCD) [2,7].
Several prognostic factors can affect the outcome
of EPN, including the radiologic typing, thrombocy-
topenia, acute renal function impairment, disturbances
of consciousness and shock [1,8,9]. Wan et al observed
the imaging findings and clinical outcomes in patients
with EPN and proposed the existence of two different
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This study compared the management, prognostic factors and outcomes of patients with emphy-
sematous pyelonephritis (EPN). Twenty-one patients with EPN were studied between September
1996 and August 2005, and were assigned to two groups. Patients in Group 1 received conserva-
tive treatment with/without percutaneous catheter drainage (PCD) while patients in Group 2
underwent nephrectomy following medical treatment and PCD. A post hoc analysis of the prog-
nostic factors was performed between survivors and nonsurvivors, and between the survivors in
Group 1 and Group 2. There were 14 patients in Group 1, and seven in Group 2. The mortality in
Group 1 was 35.7% (5/14) and in Group 2 was 0% (p = 0.12). There were no statistically significant
differences in prognostic factors between the two groups, though patients in Group 1 had rela-
tively lower platelet counts (p = 0.07) and Group 2 patients had a higher incidence of dialysis after
nephrectomy (p = 0.03). Comparing the survivors and nonsurvivors, patients with comorbid con-
gestive heart failure and patients initially presenting with consciousness disturbances had higher
mortalities (p=0.02 and p<0.01, respectively). Nonsurvivors also had lower platelet counts (p=0.06).
In conclusion, medical treatment with/without PCD can be used to manage patients with EPN.
More aggressive drainage is needed in patients with congestive heart failure who initially present
with consciousness disturbances or thrombocytopenia.
Key Words: emphysematous pyelonephritis, nephrectomy, percutaneous
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radiologic subtypes of EPN: type I and type II [1].
Type I EPN is characterized by parenchymal necrosis
with either total absence of fluid on computed tomog-
raphy (CT) images, or a streaky or mottled gas pat-
tern demonstrated by radiography or CT with lung
window display (Figure 1). Type II EPN is character-
ized either by the presence of renal or perirenal fluid
in association with a bubbly or loculated gas pattern, or
by the presence of gas in the collecting system with
acute bacterial nephritis, or renal or perirenal fluid-
containing abscesses (Figure 2). They demonstrated
higher mortality in patients with type I EPN [1]. Huang
and Tseng [8] and Wan et al [9] disclosed that patients
with thrombocytopenia, acute renal impairment, ini-
tial disturbances of consciousness and shock also had
higher mortality rates, especially when the platelet
count was < 60 × 109/L and creatinine levels were
>106.75μmol/L. These factors may affect the outcome
when comparing management strategies for EPN. 
As a consequence, the optimal strategy for treating
patients with EPN remains controversial (Table 1)
[1,2,6–14].
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Figure 1. Type I emphysematous pyelonephritis in both kidneys in a 61-year-old male. (A) Plain abdominal X-ray reveals streaky and
mottled gas (*) in both kidneys with crescent-shaped gas in the left renal fossa (curved arrow). Note that the gas extends into the para-
vertebral regions (white arrows) and bladder wall (black arrows). (B) Sonography shows gassed-out kidney (*). (C, D) Computed
tomography of the abdomen with soft tissue window and lung window settings shows streaky gas in both renal parenchymas (*) with
subcapsular gas (curved arrow) in the left side. The gas extends to the paracaval and paraaortic spaces (white arrows). This patient
underwent conservative treatment only to preserve right renal function and autonephrectomy of the left kidney.
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In this study, we retrospectively reviewed our expe-
rience in managing patients with EPN and reappraised
the prognostic factors and treatment outcomes asso-
ciated with different modalities of treatment.
METHODS
Patients
During the period from September 1996 to August
2005, 21 patients (7 male, 14 female; age range: 29–82
years, mean: 59.43 ± 15.05 years) with gas-producing
bacterial renal infections were diagnosed with EPN
and treated at our hospital. They all met the following
criteria [1,8,9]: (a) clinical manifestations of fever, chills,
and flank pain or tenderness; (b) imaging findings of
a renal lesion with gas in the renal parenchyma, collect-
ing system, or perirenal space; (c) no fistula between
the urinary tract and the bowel, and no history of
trauma or instrumentation such as urinary catheter
insertion or drainage or other possible iatrogenic
causes that could have led to gas collecting in the uri-
nary tract (such as tumor embolization or endoscopy);
and (d) positive cultures of blood, pus, or urine. Their
medical records and radiologic images were retro-
spectively reviewed, including clinical histories of
symptoms and signs, laboratory investigations, radio-
logic findings, modes of treatment, clinical courses,
and outcome.
All patients were admitted via the emergency
department, and all received adequate fluid resuscita-
tion. Blood and biochemical laboratory screening was
conducted following abdominal plain radiography.
Abdominal CT was performed in patients at high risk
of complicated nephritic disorders such as renal abscess
or EPN, especially diabetic patients with symptoms
and signs of upper urinary tract infection, including
fever, chills, knocking pain in the flank region, nausea/
vomiting, leukocytosis, or pyuria. In patients with renal
infections, EPN needed to be carefully differentiated
from other non-gas-forming renal infections such as
acute pyelonephritis, renal or perinephric abscess,
pyonephrosis and xanthogranulomatous pyelonephri-
tis. The extent of the emphysematous process was
traced and localized, which helped to define the type
of EPN. Based on the CT findings, patients were clas-
sified as having either type I or type II EPN.
Management of EPN
Empiric antibiotics were administered once EPN was
diagnosed. Blood and urine cultures were obtained
from all patients, and pus cultures were also obtained
during PCD. The antibiotics were adjusted according
to the results of the cultures and the clinical condi-
tions. Penicillin-group or cefazolin-group antibiotics
combined with gentamicin were the most frequently
administered antibiotics, based on the results of sen-
sitivity tests. Patients with coagulopathies were given
fresh frozen plasma transfusions if their international
normalized ratio was > 2, and platelet transfusions if
their platelet count was < 100 × 109/L. However, in
patients with uncorrectable coagulopathies, emergent
PCD was performed with simultaneous blood trans-
fusion. An attempt at prompt control of blood sugar
was made in diabetic patients. The management strate-
gies for these patients were divided into two groups:
(1) Group 1 patients received conservative treatment,
including medical treatment, with/without PCD; and
(2) Group 2 patients underwent nephrectomy follow-
ing medical treatment and PCD. All PCD procedures
were performed by a 24-hour on-call interventional
radiology team and two experienced interventional
radiologists (Chen YF, Tzeng YH) within 1 hour of com-
pletion of the CT. Insertion of the PCD catheter, mostly
an 8-Fr pig-tail catheter, into the renal or extrarenal
abscess was performed using the Seldinger technique
under CT guidance, or ultrasonography combined
with fluoroscopic guidance. More than one drainage
catheter was inserted in cases of non-communicating
abscess formation. During PCD, a small amount
(< 20 mL) of abscess fluid was obtained and sent for
Figure 2. Post-contrast computed tomography reveals bubbly
gas (white arrows) and fluid (*) collections in the right kidney.
This was a case of type II emphysematous pyelonephritis.
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culture. In addition to drainage of the EPN lesion,
percutaneous nephrostomy was performed simulta-
neously to release obstructive uropathy. The patient’s
vital signs, clinical symptoms and signs, and drainage
volume were closely monitored. If the drainage vol-
ume decreased and the patient’s clinical symptoms
and signs did not improve, irrigation of the drainage
tube, suction of the debris, and replacement with a
bigger catheter were performed under fluoroscopy to
maintain adequate drainage. All patients and their
families were fully informed about the procedures and
potential complications before abdominal CT or any
interventional procedures were conducted. Informed
consent was obtained from all patients.
Analysis of prognostic factors
Survivors and nonsurvivors were compared with
clarify the prognostic factors affecting the outcome
Table 1. Literature review on the management of emphysematous pyelonephritis
Authors [Ref.]
Case 
Management Recommendations & remarks
number
Wan et al [1] 38 Nephrectomy (16), PCD (12), 1. Type I EPN: emergency nephrectomy  
surgical drainage (1), 2. Perirenal or unilocular renal abscess: PCD
conservative treatment* (9) 3. Gas in the collecting system with 
obstructive uropathy: nephrostomy
Chen et al [7] 25 Elective nephrectomy Antibiotics + CT-guided PCD is an 
after drainage (3), PCD (20), acceptable alternative in treating 
conservative treatment* (2) emphysematous pyelonephritis
Shokeir et al [6] 20 Elective nephrectomy (19), Nephrectomy after rehydration, antibiotics 
conservative treatment* (1) and control of blood sugar
Wan et al [9] 38 Nephrectomy (16), PCD (12), High-risk patients have poor outcome, 
surgical drainage (1), regardless of modality of treatment
conservative treatment* (9)
Huang & Tseng [8] 48 Nephrectomy (10), PCD (33), 1. CT classes 1–2 and classes 3–4 with ≤ 2 
conservative treatment* (5) risk factors†: PCD + antibiotics 
2. Classes 3–4 with > 2 risk factors: nephrectomy
Tang et al [2] 21 Nephrectomy (2), PCD (13), Appropriate medical treatment and immediate 
conservative treatment* (6) nephrectomy or drainage
Abdul-Halim 7 Emergency nephrectomy (3), 1. Early nephrectomy 
et al [10] delayed nephrectomy  2. PCD or surgical drainage: performed in  
following PCD (2), PCD (2) patients too ill for immediate nephrectomy
Soo Park et al [11] 17 Nephrectomy (10), 1. Immediate nephrectomy 
conservative treatment* (4), 2. PCD can be an effective treatment 
PCD (3) option in inoperable cases
Wang et al [12] 26 Conservative treatment* (9), 1. Nephrectomy 
nephrectomy (10), PCD (2), 2. Antibiotics + CT-guided PCD is a reasonable 
open drainage (5) alternative in treating emphysematous 
pyelonephritis
Aswathaman 41 Conservative treatment* (5), 1. ≤ 2 risk factors: PCD + antibiotics 
et al [13] PCD with antibiotics (36) 2. > 2 risk factors: nephrectomy
Somani et al [14] 210 Conservative treatment* (24), 1. PCD should be part of the initial management 
emergency nephrectomy (64), strategy for emphysematous pyelonephritis 
open drainage (2), PCD (118) 2. Delayed elective nephrectomy may be 
required in some patients
*Conservative treatment including hydration, antibiotics, control of blood sugar in diabetics; †risk factors including thrombocytope-
nia, acute renal function impairment, disturbances of consciousness or shock. PCD = percutaneous catheter drainage; CT = computed
tomography. Note: The numbers in parentheses following the modality of treatment are the numbers of patients who received this
modality of treatment.
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and survival of EPN patients (Table 2). Disturbances
of consciousness included confusion, delirium, stupor
and coma. Thrombocytopenia was defined as serum
platelet count < 100 × 109/L. Shock was defined as a
systolic blood pressure < 90 mmHg or a shock index
(heart rate divided by systolic blood pressure) of
≥ 1.0. Macrohematuria was defined as > 100 red blood
cells per high-power field in urinary sediment. The
prognostic factors were compared between survivors
and nonsurvivors, and those prognostic factors that
contributed to increased mortality were compared
between Group 1 and Group 2 patients (Table 3).
Statistical analysis
Prognostic factors were analyzed using SPSS version
15.0 (SPSS Inc., Chicago, IL, USA) for Windows. 
Data were expressed as mean ± standard deviation. 
A p value < 0.05 was considered statistically signifi-
cant. The differences between survivors and nonsur-
vivors were tested using the Mann–Whitney U test
for continuous variables, such as platelet count and
creatinine, and Fisher’s exact test for categorical vari-
ables, such as the management modalities and prog-
nostic factors, including subtypes according to CT
classification, initial disturbance of consciousness,
shock, and history of congestive heart disease.
The differences in prognostic factors between Group
1 and Group 2 were tested using the Mann–Whitney
U test for platelet counts and Fisher’s exact test for
the other three factors, to see if any prognostic factors
affected the outcomes of Group 1 and Group 2 patients.
In addition, the Mann–Whitney U test was also per-
formed to compare the durations of hospitalization
of survivors in Groups 1 and 2, and Fisher’s exact test
was used to compare the mortalities and dialysis rates
between Group 1 and Group 2.
RESULTS
Clinical data
Fourteen (66%) of our EPN patients were women.
Eighteen (85%) patients had underlying DM, and the
three nondiabetic patients had underlying liver cir-
rhosis, right staghorn stone, and graft kidney failure
due to renal venous thrombosis, respectively. Five
(23.8%) of our patients also had obstructive uropathy.
The common clinical and laboratory presentations
were fever, chills and flank pain, flank tenderness,
leukocytosis, thrombocytopenia, acute renal function
impairment, pyuria, hematuria, and proteinuria.
Escherichia coli and Klebsiella pneumoniae were the two
Table 2. Comparison between survivors and nonsurvivors among patients with emphysematous pyelonephritis*
Characteristics Survivors (n = 16) Nonsurvivors (n = 5) Total (n = 21) p
Creatinine (μmol/L) 247.05 ± 223.41 225.7 ± 97.6 241.71 ± 198.25 0.772
Platelet count (109/L) 212.19 ± 129.36 99.38 ± 58.57 185.33 ± 125.14 0.058
Consciousness disturbance 1 (6.25) 4 (80) 5 (23.8) 0.0027
Congestive heart failure 1 (6.25) 3 (60) 4 (19.0) 0.002
Shock 1 (6.25) 2 (40) 3 (14.3) 0.128
Macrohematuria 2 (12.5) 1 (20) 3 (14.3) 1.000
Radiologic type I/II 5/11 2/3 7/14 1.000
*Data presented as mean ± standard deviation or n (%).
Table 3. Comparison between Group 1 and Group 2 patients with emphysematous pyelonephritis*
Characteristics Group 1 (n = 14) Group 2 (n = 7) Total (n = 21) p
Platelet count (109/L) 155.5 ± 126.158 245.0 ± 107.17 185.33 ± 125.14 0.073
Consciousness disturbance 5 (35.7) 0 (0) 5 (23.8) 0.123
Congestive heart failure 3 (21.4) 1 (14.3) 4 (19.0) 1.000
Radiologic type I/II 5/9 2/5 7/14 1.000
Hospitalization (d) 34.11 ± 14.41 31.43 ± 14.65 32.94 ± 14.09 0.672
Mortality 5 (35.7) 0 (0) 5 (23.8) 0.124
*Data presented as mean ± standard deviation or n (%).
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most commonly (19/21 patients, 90.5%) isolated micro-
organisms. Candida and β-hemolytic streptococci were
also isolated.
Patient management, outcome and
prognostic factors
There were 14 patients in Group 1 and seven in
Group 2. The percentages of type I and type II EPN
were 35.7% (5/14) and 64.3% (9/14), and 28.5% (2/7)
and 71.5% (5/7) in Groups 1 and 2, respectively. The
overall mortality and the mortalities in Group 1 and
Group 2 were 23.8%, 35.7% and 0%, respectively. The
mortalities in patients with type I EPN and type II
EPN were 28.5% and 21.4% (p = 1.00), respectively.
The durations of hospitalization of the survivors in
Group 1 and Group 2 were 34.11 ± 14.41 days and
31.43 ± 14.65 days (p = 0.67), respectively. There were
no statistically significant differences between the two
groups in terms of mortality, duration of hospitaliza-
tion, or other prognostic factors (Table 3), although
patients in Group 1 had a relatively lower platelet
count (155.5 ± 126.158 × 109/L, p = 0.07). Additionally,
no patient who received nonsurgical treatment re-
quired dialysis, although three patients who under-
went nephrectomy required dialysis (p = 0.03).
Although there were no significant differences in
prognostic factors between these two groups, most
patients with initial consciousness disturbances (5/5,
100%), underlying congestive heart failure (3/4, 75%)
or thrombocytopenia (8/9, 90%) were inoperable and
were thus included in Group 1. These factors contrib-
uted to the mortality, especially in Group 1 patients.
There were no statistically significant differences
between the survivors and nonsurvivors with respect
to most prognostic factors (Table 2), except for four
patients with underlying congestive heart failure
(p=0.02) and five patients who initially presented with
consciousness disturbances (p < 0.01) and who had
higher mortalities. Nonsurvivors also had lower
platelet counts (99.38 ± 58.57 × 109/L, p = 0.06), though
this difference was not statistically significant.
DISCUSSION
EPN is an uncommon infectious process that deserves
special attention because of its high mortality [1].
EPN affects women more commonly than men, pre-
sumably because of their increased susceptibility to
urinary tract infections [6]. Factors involved in the
pathogenesis of EPN include high levels of tissue
glucose and impaired host immunity, the presence of
glucose-fermenting bacteria (gas-forming coliform
bacteria such as E. coli and K. pneumoniae), impaired
tissue perfusion, and obstruction of the urinary tract
[15,16]. These may explain why most patients are
poorly-controlled diabetics, and why E. coli and 
K. pneumoniae are the most commonly isolated organ-
isms. EPN can also be encountered in non-diabetics
or in well-controlled diabetic patients suffering from
immunodeficiencies resulting from conditions such
as alcoholism, liver cirrhosis, renal grafting, or in
patients with obstructive uropathy [2,6].
Because no specific symptoms, signs, or labora-
tory data can be used to distinguish EPN from other
upper urinary tract infections, further investigations
using a variety of imaging studies such as CT should
be initiated, especially in diabetic patients thought to
have uncomplicated pyelonephritis but with a poor
response to antibiotic therapy [3,6].
Treatment of EPN has been controversial (Table 1)
[1,2,6–14]. The majority of studies have reported on
the management of EPN with nephrectomy. For
example, Shokeir et al recommended nephrectomy
immediately after vigorous rehydration, intravenous
antibiotics and control of blood sugar, and suggested
that nephrectomy should not be delayed, even if the
patient begins to improve [6]. They found that PCD
combined with medical therapy was unable to pre-
serve renal function or reduce morbidity [6]. However,
more conservative management of patients with EPN
has been proposed [1,7,10–14]. Wan et al identified
two distinct radiologic types of EPN: type I and type
II [1]. It is important to differentiate between these
due to prognostic differences: type I has a fulminant
clinical course and a subsequently poor prognosis,
while type II has a slower clinical course and a better
outcome. Wan et al suggested that emergency nephrec-
tomy was the optimal treatment method for type I
EPN. PCD is indicated for patients with perirenal or
unilocular renal abscesses, and nephrostomy is indi-
cated for gas in the collecting system with obstructive
uropathy [1]. Chen et al described their experience of
treating 25 EPN patients over the course of 10 years
[7]. Of the 25 patients, 80% required only conserva-
tive treatment. Huang and Tseng classified their EPN
patients into four classes according to the extent of
the lesions on CT images: within the collecting system
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(class 1), parenchyma (class 2), perirenal or pararenal
space (class 3), and within both kidneys or anywhere
in a solitary kidney (class 4) [8]. They demonstrated
that patients in classes 1 and 2 survived after com-
bined PCD and antibiotic treatment and could have
preserved renal function. For patients in classes 3 and
4 with more than two risk factors, nephrectomy pro-
vided the best outcome [8]. Abdul-Halim et al [10]
and Soo Park et al [11] suggested that early nephrec-
tomy offered the best outcome, and that PCD should
be reserved for inoperable patients. Aswathaman et al
[13] and Somani et al [14] recommended that PCD
should be part of the initial treatment of patients with
EPN, and that nephrectomy may be required in some
patients, such as those with high risks.
Surgeons who prefer nephrectomy consider that,
when the abscess is confined within Gerota’s fascia,
nephrectomy following nonsurgical treatment will
rapidly control sepsis and reduce the duration of hos-
pitalization. It is believed that aggressive EPN will im-
pair tissue perfusion and cause extensive infarction,
resulting in a reduced blood supply and subsequent
failure of leukocytes and antibiotics to reach the af-
fected area. The affected tissue can be removed en bloc
with less manipulation so reducing the chance of the
septic source spreading into the blood stream.
Other clinicians prefer vigorous hydration, intra-
venous antibiotics and PCD, with control of blood
sugar if a patient has DM, and percutaneous nephros-
tomy is indicated if obstructive uropathy is present. The
role of interventional radiologists in the conservative
treatment of EPN cannot be overlooked. Experienced
radiologists are required to place the drainage tube in
the right location, irrigate the catheter and suck out the
debris frequently, to search for non-communicating
abscess cavities and to carefully evaluate indications for
further PCD catheter insertion. All these measures con-
tribute to the success of conservative treatment of EPN.
Although no patients who underwent nephrec-
tomy died in our study, these results may be biased,
because some patients who were treated medically
did not undergo surgery due to inherent risks, such
as disseminated intravascular coagulopathy, hemo-
dynamic instability, or a rapid clinical course with
multiple organ dysfunction. Consequently, several
prognostic factors can affect the comparative evalua-
tion and outcome of different treatment strategies for
the management of EPN. These prognostic factors
include thrombocytopenia, impaired renal function,
macrohematuria, disturbances of consciousness, shock,
and type I EPN. In comparison with type II EPN,
patients with type I EPN tend to have a defective
immune reaction with disseminated intravascular
coagulation, leading to renal thrombosis and a poor
prognosis [9]. Macrohematuria implies severe necro-
sis or destruction of the kidney due to the infectious
process and the presence of renal vein thrombosis [9].
In our study, two prognostic factors—disturbances
of consciousness and congestive heart failure—showed
statistically significant differences between survivors
and nonsurvivors. Congestive heart failure has not
previously been proposed as a prognostic factor, but
it may be indicative of poor autoregulatory cardio-
vascular function when encountering septic compli-
cations. Platelet counts differed between survivors
and nonsurvivors, though the difference was not sta-
tistically significant. Although the differences in prog-
nostic factors between patients in Group 1 and Group 2
were not significant, patients with initial presentations
of consciousness disturbances, thrombocytopenia, or
a history of congestive heart failure might have con-
tributed to the mortality of Group 1 patients.
Nephrectomy cannot preserve renal function, but
nonsurgical treatment can allow for preserved renal
function if the kidney has not been overwhelmingly
destroyed by the disease. Under modern intensive
care with liberal use of antibiotics and the innovative
techniques of PCD and PCD revision, successful con-
servative treatment of EPN has been increasingly
reported [2,13,14]. In our study, we found that con-
servative treatment could successfully treat patients
with EPN while preserving most of their renal func-
tion, except in five patients who had more than two
of the three risk factors (disturbances of consciousness,
thrombocytopenia or a history of congestive heart
failure) and who were all inoperable.
In comparison with nephrectomy, a shortcoming
of nonsurgical treatment is that multiloculated ab-
scesses may be present in patients with EPN, which
may require more than one drainage tube for adequate
drainage, or may need repeated revision with irriga-
tion and suction of the debris under fluoroscopic
guidance. Moreover, more than one CT examination
may be indicated to evaluate non-communicating
abscesses. All these procedures increase the costs of
medical treatment.
Our study was limited by: (1) small sample size
that may have led to an inability to detect statistically
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significant differences in mortality between patients
with type I and type II EPN, in some prognostic fac-
tors between Groups 1 and 2, or between survivors
and nonsurvivors; (2) this was a retrospective review
study and there was no randomized control. However,
because EPN is an uncommon disease and several
factors can affect the outcomes, a fully randomized
study is difficult to conduct.
Although the sample size in our study was small,
the use of suitable statistical analyses allowed us to
demonstrate that intensive medical control, combined
with adequate drainage, was an effective alternative
modality for the management of patients with EPN,
allowing the preservation of renal function without
prolonging the duration of hospitalization. Inoperable
patients with poor prognostic factors, including under-
lying heart failure, initial presentation with conscious-
ness disturbances, or thrombocytopenia, need more
vigorous hydration combined with antibiotic therapy,
control of blood sugar, and aggressive PCD with/
without nephrostomy to improve their treatment
outcomes and reduce mortality.
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產氣性腎盂腎炎治療方法及其預後之再評估
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此研究之目的在比較產氣性腎盂腎炎的各種治療方法及其預後和預後的因子。自 1996 
年九月到 2005 年八月期間，共有 21 位罹患產氣性腎盂腎炎的病人被納入這研究中。
我們將這些病人分為兩組：第一組病人是接受保守治療包含內科治療，同時有無合併
經皮導管引流術；第二組病人是在接受保守治療後接受患側腎臟切除術。最後利用統
計分析的方法來比較預後因子在生存者及非生存者間的差異，以及在生存者中的第一
組和第二組病人間的差異。第一組病人共有 14 位，第二組病人共有 7 位。其死亡率
在第一組病人是 35.7% 在第二組病人是 0% (p = 0.12)。而預後因子分析在這二組病
人並無統計學上的差異，除了第一組的病人血液中有相對比較低的血小板數 (p = 
0.07) 及第二組病人在接受患側腎臟切除術後有比較高的機會需要接受長期的透析治
療 (p = 0.03)。在比較生存者及非生存者間的差異時發現，病人若合併有充血性心臟
衰竭或一開始就呈現意識混亂的病人死亡率較高 (p = 0.02 及 p < 0.01)。同時非生存
者血液中有比較低的血小板數 (p = 0.06)。結論是﹕內科治療同時有無合併經皮導管
引流術可以是治療產氣性腎盂腎炎的替代治療方式；然而若病人合併有充血性心臟衰
竭或一開始就呈現意識混亂或血液中有比較低的血小板數的病人，需要施行更積極的
經皮導管引流術。
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